References and Notes
1a
Andersen RJ.
Faulkner DJ.
Cun-heng H.
Van Duyne GD.
Clardy J.
J. Am. Chem. Soc.
1985,
107:
5492
1b
Cironi P.
Albericio F.
Alvarez M. In Progress in Heterocyclic Chemistry
Vol. 16:
Gribble GW.
Joule JA.
Pergamon;
Oxford:
2004.
p.1-26
2a
Yamaguchi T.
Fukuda T.
Ishibashi F.
Iwao M.
Tetrahedron Lett.
2006,
47:
3755
2b
Fujikawa N.
Ohta T.
Yamaguchi T.
Fukuda T.
Ishibashib F.
Iwao M.
Tetrahedron
2006,
62:
594
2c
Iwao M.
Takeuchi T.
Fujikawa N.
Fukuda T.
Ishibashi F.
Tetrahedron Lett.
2003,
44:
4443
3a
Díaz M.
Guitián E.
Castedo L.
Synlett
2001,
1164
3b
Zhao B.-X.
Yu Y.
Eguchi S.
Tetrahedron
1996,
52:
12049
4
Olsen CA.
Parera N.
Albericio F.
Alvarez M.
Tetrahedron Lett.
2005,
46:
2041
5a
Ploypradith P.
Kagan RK.
Ruchirawat S.
J. Org. Chem.
2005,
70:
5119
5b
Ploypradith P.
Mahidol C.
Sahakitpichan P.
Wongbundit S.
Ruchirawat S.
Angew. Chem. Int. Ed.
2004,
43:
866
5c
Kuo R.-Y.
Wu C.-C.
Chang F.-R.
Yeh J.-L.
Chen I.-J.
Wu Y.-C.
Bioorg. Med. Chem. Lett.
2003,
13:
821
5d
Ishibashi F.
Tanabe S.
Oda T.
Iwao M.
J. Nat. Prod.
2002,
65:
500
5e
Ruchirawat S.
Mutarapat T.
Tetrahedron Lett.
2001,
42:
1205
6
Fujita R.
Watanabe N.
Tomisawa H.
Chem. Pharm. Bull.
2002,
50:
225
7a
La Porta P.
Capuzzi L.
Bettarini F.
Synthesis
1994,
287
7b
DeShong P.
Kell DA.
Sidler DR.
J. Org. Chem.
1985,
50:
2309
7c
Padwa A.
Norman BH.
J. Org. Chem.
1990,
55:
4801
7d
Cironi P.
Cuevas C.
Albericioa F.
Alvarez M.
Tetrahedron
2004,
60:
8669
7e
Cironi P.
Manzanares I.
Albericio F.
Alvarez M.
Org. Lett.
2003,
2959
7f
Ridley CPM.
Reddy VR.
Rocha G.
Bushman FD.
Faulkner DJ.
Bioorg. Med. Chem.
2002,
10:
3285
7g
Banwell M.
Flynn B.
Hockless D.
Chem. Commun.
1997,
2259
7h
Poissonnet G.
Theret-Bettiol M.-H.
Dodd RH.
J. Org. Chem.
1996,
61:
2273
8a
Southwick PL.
Sapper DI.
Pursglove LA.
J. Am. Chem. Soc.
1950,
72:
4940
8b
Cossy J.
Pete J.-P.
Tetrahedron Lett.
1978,
4941
8c
Cervinka O.
Chem. Ind. (London)
1959,
1129
8d
Oussaid B.
Garrigues B.
Soufiaoui M.
Can. J. Chem.
1994,
72:
2483
8e
Bonnaud B.
Bigg DCH.
Synthesis
1994,
465
8f
Gupta P.
Bhaduri AP.
Synth. Commun.
1998,
28:
3151
9a
Bende Z.
Simon K.
Tóth G.
Tõke L.
Weber L.
Liebigs Ann. Chem.
1982,
924
9b
Bende Z.
Bitter I.
Tõke L.
Weber L.
Tóth G.
Janke F.
Liebigs Ann. Chem.
1982,
2146
9c
Bende Z.
Tõke L.
Weber L.
Tóth G.
Janke F.
Csonka G.
Tetrahedron
1983,
40:
369
9d
Tischer T.
Tõke L.
Tóth G.
Acta Chim. Hung.
1990,
127:
171
9e
Fejes I.
Nyerges M.
Tõke L.
Pak CS.
Tetrahedron
2000,
56:
639
9f
Fejes I.
Nyerges M.
Szöllõssy Á.
Blaskó G.
Tõke L.
Tetrahedron
2001,
57:
1129
9g
Nyerges M.
Somfai B.
Tóth J.
Dancsó A.
Blaskó G.
Tõke L.
Synthesis
2005,
2039
10
Filler R.
Chem. Rev.
1963,
63:
21
11a
Ali MH.
Hartman M.
Lamp K.
Schmitz C.
Wencewicz T.
Synth. Commun.
2006,
36:
1769
11b
Harville R.
Rees SF.
J. Org. Chem.
1968,
33:
3976
11c
More KM.
Wemple J.
Synthesis
1977,
791
11d
Surendra K.
Krishnaveni NS.
Kumar VP.
Sridhar R.
Rao KR.
Tetrahedron Lett.
2005,
46:
4581
12a
Jain SL.
Sain B.
Synth. Commun.
2006,
36:
1459
12b
Lee JC.
Lee JY.
Lee JM.
Synth. Commun.
2005,
35:
1911
12c
Sharma VB.
Jain SL.
Sain B.
J. Mol. Catal. A: Chem.
2005,
227:
47
12d
Khurana JM.
Kandpal BM.
Tetrahedron Lett.
2003,
44:
4909
13
Cheung YF.
Tetrahedron Lett.
1979,
40:
3809
14
Bandgar BP.
Makone SS.
Synth. Commun.
2006,
36:
1347
15
Tatsugi J.
Zhiwei T.
Izawa Y.
ARKIVOC
2001,
(i):
67
16
Suzuki H.
Tsutsui H.
Kano A.
Katoh S.
Morita T.
Matsuda K.
Iibuchi N.
Ogawa M.
Heterocycles
1997,
45:
1657
17
Kovganko VN.
Kovganko NN.
Russ. J. Org. Chem.
2006,
42:
243
18a
Pelletier JC.
Cava MP.
J. Org. Chem.
1987,
52:
616
18b
Pelletier JC.
Cava MP.
Synthesis
1987,
474
19
Stanforth SP.
J. Heterocycl. Chem.
1987,
531
20
General procedure for the preparation of compounds 5a-l: The corresponding cycloadduct (4, 1.0 mmol) was dissolved in CHCl3 (10 mL) and NBS (0.17 g, 1.1 mmol) was added in one portion. The solution immediately turned yellow. After 30 min stirring H2O (10 mL) was added and the organic layer was washed with further portions of H2O (2 × 10 mL) and brine (10 mL), then dried (MgSO4) and evaporated in vacuo. The residue was triturated with cold EtOH and filtered to yield the title product as a yellow powder. All new compounds afforded correct elemental analyses and spectroscopic data.
Selected examples: Methyl 8,9-dimethoxy-1-nitro-2-phenyl-5,6-dihydropyrrolo[2,1-a]isoquinoline-3-carboxylate (5a): IR (KBr): 2956, 2833, 1700, 1609, 1591, 1561, 1547, 1506, 1452, 1439, 1355, 1284, 1262, 1236, 1217, 1195, 1181, 1136, 1100, 1072, 1016 cm-1; 1H NMR (500 MHz, CDCl3): δ = 7.39 (m, 4 H, Ph-H and H-10), 7.29 (m, 2 H, Ph-H), 6.79 (s, 1 H, H-7), 4.58 (t, J = 6.7 Hz, 2 H, H-5), 3.94 (s, 3 H, OMe), 3.86 (s, 3 H, OMe), 3.53 (s, 3 H, OMe), 3.06 (t, J = 6.7 Hz, 2 H, H-6); 13C NMR (125 MHz, CDCl3): δ = 161.3 (q), 150.2 (q), 147.9 (q), 136.4 (q), 132.3 (q), 130.9 (q), 129.6 (q), 129.5 (2 × CH), 128.1 (q), 127.8 (CH), 127.6 (2 × CH), 117.2 (q), 114.7 (q), 110.5 (CH), 109.9 (CH), 56.5 (CH3), 56.0 (CH3), 51.4 (CH3), 43.0 (CH2), 28.8 (CH2).
Methyl 8,9-dimethoxy-2-(2-bromo-3,4,5-trimethoxy-phenyl)-1-nitro-5,6-dihydropyrrolo[2,1-a]isoquinoline-3-carboxylate (5e): IR (KBr): 2993, 2940, 2840, 1709, 1669, 1563, 1505, 1475, 1443, 1427, 1410, 1387, 1361, 1343, 1301, 1287, 1260, 1214, 1195, 1138, 1107, 1049, 1013 cm-1; 1H NMR (500 MHz, CDCl3): δ = 7.49 (s, 1 H, H-10), 6.79 (s, 1 H, H-7), 6.63 (s, 1 H, Ar2-6′H), 4.61 (m, 2 H, H-5), 3.96 (s, 3 H, OMe), 3.95 (s, 3 H, OMe), 3.93 (s, 3 H, OMe), 3.89 (s, 3 H, OMe), 3.83 (s, 3 H, OMe), 3.06 (m, 2 H, H-6); 13C NMR (125 MHz, CDCl3): δ = 160.9 (q), 152.2 (q), 150.7 (q), 150.4 (q), 147.7 (q), 142.5 (q), 131.6 (q), 131.5 (q), 129.7 (q), 128.0 (q), 127.4 (q), 118.6 (q), 117.1 (q), 111.0 (q), 110.5 (CH), 110.4 (CH), 109.8 (CH), 61.2 (CH3), 61.0 (CH3), 56.13 (CH3), 56.12 (CH3), 56.0 (CH3), 51.7 (CH3), 43.0 (CH2), 28.8 (CH2).
3-(4-Bromobenzoyl)-2-(2-chlorophenyl)-8,9-dimethoxy-1-nitro-5,6-dihydropyrrolo[2,1-a]isoquinoline (5k): IR (KBr): 3010, 2943, 1633, 1586, 1502, 1471, 1442, 1405, 1355, 1261, 1218, 1148, 1095, 1068, 1056, 1014 cm-1; 1H NMR (500 MHz, CDCl3): δ = 7.54 (s, 1 H, H-10), 7.41 (d, J = 8.4 Hz, 2 H, Ar3-2′ and 6′H), 7.25 (d, J = 8.4 Hz, 2 H, Ar3-3′ and 5′H), 7.19 (d, J = 7.9 Hz, 1 H, Ar2-6′H), 7.07 (t, J = 7.9 Hz, 1 H, Ar2-5′H), 6.97 (d, J = 7.9 Hz, 1 H, Ar2-3′H), 6.95 (d, J = 7.9 Hz, 1 H, Ar2-4′H), 6.81 (s, 1 H, H-7), 4.45 (m, 1 H, H-5), 4.34 (m, 1 H, H-5), 3.96 (s, 3 H, OMe), 3.90 (s, 3 H, OMe), 3.10 (m, 2 H, H-6); 13C NMR (125 MHz, CDCl3): δ = 186.6 (q), 150.6 (q), 147.8 (q), 136.7 (q), 134.3 (q), 133.1 (q), 132.3 (CH), 132.2 (q), 131.0 (q), 130.9 (2 × CH), 130.5 (2 × CH), 129.3 (CH), 129.1 (CH), 128.3 (q), 127.5 (q), 126.7 (q), 126.3 (CH), 125.3 (q), 117.0 (q), 110.6 (CH), 110.5 (CH), 56.2 (CH3), 56.0 (CH3), 43.3 (CH2), 29.0 (CH2).
21
Fejes I.
Nyerges M.
Blaskó G.
Tőke L.
Pak CS.
Tetrahedron
2000,
43:
8545
22
Nyerges M.
Tőke L.
Tetrahedron Lett.
2005,
46:
7531